Cilostazol Protects Endothelial Cells Against Lipopolysaccharide-Induced Apoptosis Through ERK1/2- and P38 MAPK-Dependent Pathways

키워드

참고문헌 (38)

1. Kimura Y, "Effect of cilostazol on platelet aggregation and experimental thrombosis", Arzneinmittelforschung, 35, pp.1144~1149 (1985)
2. Kohda N, "Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery", Thromb Res, 96, pp.261~268 (1999)
3. Tanaka K, "Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia", Stroke, 20, pp.668~673 (1989)
4. Dawson DL, "Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial", Circulation, 98, pp.678~686 (1998)
5. fer AM, "Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock", Annu Rev Pharmacol Toxicol, 33, pp.71~90 (1993)
6. Ten VS, "Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction", Curr Opin Crit Care, 8, pp.242~250 (2002)
7. Minor T, "Role of the hepatovasculature in free radical mediated reperfusion damage of the liver", Eur Surg Res, 25, pp.287~293 (1993)
8. Scalia R, "Time course of endothelial dysfunction and neutrophil adherence and infiltration during murine traumatic shock", Shock, 6, pp.177~182 (1996)
9. Hack CE, "The endothelium in sepsis: source of and a target for inflammation", Crit Care Med, 29(7), pp.s21~s27 (2001)
10. Kim KY, "Inhibition of LPSinduced apoptosis by cilostazol in human umbilical vein endothelial cells", J Pharmacol Exp Ther, 300, pp.709~715 (2002)
11. Hong KW, "Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt", cyclic AMP responseelement-binding protein phosphorylation, 2003, pp.306, 1182~1190
12. Choi JM, "Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats", J Pharmacol Exp Ther, 300, pp.787~793 (2002)
13. Johnson GL, "Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases", Science, 298, pp.1911~1912 (2002)
14. Wada T, "Mitogen-activated protein kinases in apoptosis regulation", Oncogene, 23, pp.2838~2849 (2004)
15. Davis RJ, "Signal transduction by the JNK group of MAP kinases", Cell, 103, pp.239~252 (2000)
16. Pastorino JG, "The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition", J Biol Chem, 273, pp.7770~7775 (1998)
17. Lemasters JJ, "The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy", Biochim Biophys Acta, 1366, pp.177~196 (1998)
18. Favata MF, "Identification of a novel inhibitor of mitogen-activated protein kinase kinase", J Biol Chem, 273, pp.18623~18632 (1998)
19. Cirillo PF, "The non-diaryl heterocycle classes of p38 MAP kinase inhibitors", Curr Top Med Chem, 2, pp.1021~1035 (2002)
20. Bennett BL, "SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase", Proc Natl Acad Sci U S A, 98, pp.13681~13686 (2001)
21. Ozoren N, "The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand", Cancer Res, 60, pp.6259~6265 (2000)
22. Akita K, "Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP1 cells", J Biol Chem, 272, pp.26595~26603 (1997)
23. van Noorden CJ, "The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition", Acta Histochem, 103, pp.241~251 (2001)
24. Talanian RV, "Substrate specificities of caspase family proteases", J Biol Chem, 272, pp.9677~9682 (1997)
25. Kroemer G, "The mitochondrial death", life regulator in apoptosis and necrosis, 1998, pp.60, 619~642
26. Mayr B, "Transcriptional regulation by the phosphorylation-dependent factor CREB", Nat Rev Mol Cell Biol, 2, pp.599~609 (2001)
27. Nishihara H, "Cyclic AMP promotes cAMP-responsive element-binding proteindependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1", 2 and p38 MAPK, 2004, pp.279, 26176~26183
28. Sprick MR, "The interplay between the Bcl-2 family and death receptor-mediated apoptosis", Biochim Biophys Acta, 644, pp.125~132
29. Hotchkiss RS, "Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction", Crit Care Med, 27, pp.1230~1251 (1999)
30. Bannerman DD, "A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis", J Biol Chem, 276, pp.14924~14932 (2001)
31. Munshi N, "Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor", J Immunol, 168, pp.5860~5866 (2002)
32. Hoyt DG, "Integrins inhibit LPS-induced DNA strand breakage in cultured lung endothelial cells", Am J Physiol, 270, pp.l689~l694 (1996)
33. Wort SJ, "The role of the endothelium in modulating vascular control in sepsis and related conditions", Br Med Bull, 55, pp.30~48 (1999)
34. Haimovitz-Friedman A, "Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation", J Exp Med, 186, pp.1831~1841 (1997)
35. Zhang XM, "Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide", Microbiol Immunol, 38, pp.669~671 (1994)
36. Cobb MH, "MAP kinase pathways", Prog Biophys Mol Biol, 71, pp.479~500 (1999)
37. Xia Z, "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis", Science, 270, pp.1326~1231 (1995)
38. Xiang H, "Role of the cyclic AMP response element in the Bcl-2 Promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B Cells", Mol Cell Biol, 26, pp.8599~8606 (2006)

관련 논문AI추천